HK · Healthcare

Mirxes Holding Co Ltd (2629)

Biotechnology

Mirxes Holding Co Ltd (2629) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $3.70B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 2629

Market cap
$3.70B
P/E ratio
18.00
Gross profit (TTM)
$11.32M
Net margin
0.0%

Mirxes Holding Co Ltd (2629) — FAQ

What is Mirxes Holding Co Ltd's market cap?

Mirxes Holding Co Ltd (2629) has a reported market cap of $3.70B (data as of 2026-05-21).

What is 2629's P/E ratio?

The price-to-earnings (P/E) ratio for Mirxes Holding Co Ltd (2629) is 18.00 (data as of 2026-05-21).

Does Mirxes Holding Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Mirxes Holding Co Ltd (2629). Check the MyAverix Finance app for the latest dividend data.

What sector is Mirxes Holding Co Ltd in?

Mirxes Holding Co Ltd (2629) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 2629 listed on?

2629 is listed on HK.

What is Mirxes Holding Co Ltd's net margin?

Mirxes Holding Co Ltd (2629) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play